Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient

Details for Australian Patent Application No. 2007311957 (hide)

Owner Forerunner Pharma Research Co., Ltd.

Inventors Kimura, Naoki

Agent FB Rice

Pub. Number AU-A-2007311957

PCT Pub. Number WO2008/047925

Priority 2006-286824 20.10.06 JP; 2007-107207 16.04.07 JP

Filing date 19 October 2007

Wipo publication date 24 April 2008

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/047925 Priority application(s): WO2008/047925

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007311968-Lytic enzyme inhibitor, lysis inhibitor, inhibitor of degradation of polygamma-glutamic acid, and method for production of poly-gamma-glutamic acid

2007311946-Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient